UA108498C2 - Condensed pirolokarbazol derivative purifying method - Google Patents
Condensed pirolokarbazol derivative purifying methodInfo
- Publication number
- UA108498C2 UA108498C2 UAA201214484A UAA201214484A UA108498C2 UA 108498 C2 UA108498 C2 UA 108498C2 UA A201214484 A UAA201214484 A UA A201214484A UA A201214484 A UAA201214484 A UA A201214484A UA 108498 C2 UA108498 C2 UA 108498C2
- Authority
- UA
- Ukraine
- Prior art keywords
- condensed
- pirolokarbazol
- purifying method
- derivative
- derivative purifying
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- AEULIVPVIDOLIN-UHFFFAOYSA-N cep-11981 Chemical compound C1=C2C3=C4CNC(=O)C4=C4C5=CN(C)N=C5CCC4=C3N(CC(C)C)C2=CC=C1NC1=NC=CC=N1 AEULIVPVIDOLIN-UHFFFAOYSA-N 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- -1 pyrrolocarbazole compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34583110P | 2010-05-18 | 2010-05-18 | |
| PCT/US2011/036814 WO2011146488A1 (en) | 2010-05-18 | 2011-05-17 | Method for purifying a fused pyrrolocarbazole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA108498C2 true UA108498C2 (en) | 2015-05-12 |
Family
ID=44168420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201214484A UA108498C2 (en) | 2010-05-18 | 2011-05-17 | Condensed pirolokarbazol derivative purifying method |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8884014B2 (enExample) |
| EP (1) | EP2571885B1 (enExample) |
| JP (2) | JP5828594B2 (enExample) |
| KR (1) | KR101815332B1 (enExample) |
| CN (1) | CN102958934B (enExample) |
| AU (1) | AU2011256264B2 (enExample) |
| BR (1) | BR112012029374B1 (enExample) |
| CA (1) | CA2799517C (enExample) |
| CL (1) | CL2012003208A1 (enExample) |
| EA (1) | EA021869B1 (enExample) |
| ES (1) | ES2530015T3 (enExample) |
| IL (2) | IL223016A0 (enExample) |
| MX (1) | MX2012013304A (enExample) |
| MY (1) | MY156830A (enExample) |
| NZ (1) | NZ604135A (enExample) |
| PH (1) | PH12012502250A1 (enExample) |
| SG (2) | SG10201503541WA (enExample) |
| UA (1) | UA108498C2 (enExample) |
| WO (1) | WO2011146488A1 (enExample) |
| ZA (1) | ZA201209305B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103965204B (zh) | 2008-11-19 | 2016-09-07 | 赛福伦公司 | 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109229B2 (en) * | 2000-09-29 | 2006-09-19 | Eli Lilly And Company | Methods and compounds for treating proliferative diseases |
| US7169802B2 (en) * | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| JP2006241579A (ja) | 2005-03-07 | 2006-09-14 | Nippon Paint Co Ltd | 化成処理剤及び表面処理金属 |
| CN103965204B (zh) * | 2008-11-19 | 2016-09-07 | 赛福伦公司 | 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 |
-
2011
- 2011-05-17 PH PH1/2012/502250A patent/PH12012502250A1/en unknown
- 2011-05-17 KR KR1020127032917A patent/KR101815332B1/ko active Active
- 2011-05-17 MX MX2012013304A patent/MX2012013304A/es active IP Right Grant
- 2011-05-17 EA EA201291269A patent/EA021869B1/ru not_active IP Right Cessation
- 2011-05-17 WO PCT/US2011/036814 patent/WO2011146488A1/en not_active Ceased
- 2011-05-17 AU AU2011256264A patent/AU2011256264B2/en active Active
- 2011-05-17 JP JP2013511294A patent/JP5828594B2/ja active Active
- 2011-05-17 ES ES11721691.1T patent/ES2530015T3/es active Active
- 2011-05-17 UA UAA201214484A patent/UA108498C2/ru unknown
- 2011-05-17 MY MYPI2012004977A patent/MY156830A/en unknown
- 2011-05-17 BR BR112012029374-5A patent/BR112012029374B1/pt active IP Right Grant
- 2011-05-17 CA CA2799517A patent/CA2799517C/en active Active
- 2011-05-17 CN CN201180024787.XA patent/CN102958934B/zh active Active
- 2011-05-17 SG SG10201503541WA patent/SG10201503541WA/en unknown
- 2011-05-17 SG SG2012084851A patent/SG185645A1/en unknown
- 2011-05-17 NZ NZ604135A patent/NZ604135A/en unknown
- 2011-05-17 EP EP11721691.1A patent/EP2571885B1/en active Active
-
2012
- 2012-11-13 IL IL223016A patent/IL223016A0/en active IP Right Grant
- 2012-11-16 US US13/678,886 patent/US8884014B2/en active Active
- 2012-11-16 CL CL2012003208A patent/CL2012003208A1/es unknown
- 2012-12-07 ZA ZA2012/09305A patent/ZA201209305B/en unknown
-
2015
- 2015-10-19 JP JP2015205469A patent/JP2016074668A/ja active Pending
- 2015-10-22 IL IL242221A patent/IL242221B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012006180A2 (pt) | processos e intermediários para a preparação de análogos de 1'-substituido carba-nucleosídeo | |
| PH12016500867A1 (en) | Pyrrolo [1,2,f] [1,2,4] triazines useful for treating respiratory syncitial virus infections | |
| EP2608669A4 (en) | NEW PYRAZOLO- [1,5-A-] PYRIMIDINE DERIVATIVES AS ANTI-MTOR HEMMER | |
| UY33801A (es) | COMPUESTOS SUSTITUIDOS DE N-(1H-INDAZOL-4IL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA TIROSINA QUINASA RECEPTORA DE TIPO III | |
| BR112013022917A2 (pt) | derivados 3,4-dihidro-pirrolo[1,2-a]pirazino-1-ilamina úteis como inibidores de beta-secretase (bace) | |
| EP3778606A3 (en) | Condensed imidazolylimidazoles as antiviral compounds | |
| WO2013078170A8 (en) | Purification of anti-c-met antibodies | |
| EA201290988A1 (ru) | Стереоселективный синтез фосфорсодержащих активных соединений | |
| EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
| ZA201306545B (en) | 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of betasecretase (bace) | |
| UY33325A (es) | Purificación mediante adsorción de colorante caramelo | |
| CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
| EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
| CL2011001947A1 (es) | Compuestos derivados de fenil-{1,2,4}triazolo[1,5-a]piridin-fenilamino sustituidos, inhibidores de cinasa; utiles para tratar trastornos asociados con la permeabilidad vascular. | |
| WO2011132051A3 (en) | Tricycle compounds as phosphodiesterase-10 inhibitors | |
| EP2738153A4 (en) | PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE | |
| WO2007016635A3 (en) | Process for the purification of coenzyme q10 | |
| IN2014KN01062A (enExample) | ||
| EA201892052A1 (ru) | Способ получения органических соединений | |
| WO2009062659A3 (en) | Polymorphs of enantiopure erdosteine | |
| EA201590116A1 (ru) | Способ получения замещенных триазолопиридинов | |
| CA2901162C (en) | Purification of rapamycin derivatives | |
| EA201291269A1 (ru) | Способ очистки конденсированного производного пирролокарбазола | |
| AU2012280208B2 (en) | Carboxylic acid derivatives having Oxazolo [5, 4-D] Pyrimidine ring | |
| WO2012051601A3 (en) | Heteroarylthio compounds |